Prime Medicine Inc.
PRME | NASDAQ
$3.19
+$0.07 (+2.24%)
At close: Sep 21, 2026, 4:00 PM ET
$3.04
-$0.15 (-4.83%)
Pre-market:
Sep 22, 2026, 4:16 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.15M | 856K | 838K | 1.23M | 1.12M | 1.45M | 2.18M | 209K | n/a | 591K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 1.86M | n/a | 43.99M | 1.86M | n/a | n/a | n/a | n/a | 1.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.16M | 4.57M |
Gross Profit | 1.15M | -1M | 838K | -42.77M | -749K | 1.45M | 2.18M | 209K | n/a | -724K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.16M | -4.57M |
Operating Income | -43.29M | -50.65M | -48.61M | -53.97M | -53.38M | -52.39M | -44.22M | -54.23M | -55.67M | -48.34M | -68.04M | -51.46M | -45.26M | -40.03M | -38.69M | -31.66M | -26.31M | -19.9M | -60.08M | -10.43M | -8.02M | -5.96M |
Interest Income | 788K | 1.48M | 1.08M | 1.14M | 1.27M | 1.18M | 1.54M | 697K | 611K | 676K | n/a | 410K | 635K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -42.11M | -49.12M | -46.08M | -50.58M | -52.59M | -51.89M | -42.28M | -52.52M | -55.46M | -45.63M | -65.64M | -50.82M | -42.35M | -39.6M | -39.47M | -29.14M | -29.79M | -24.37M | -61.53M | -18.78M | 1.73M | -87.28M |
Net Income | -42.11M | -49.12M | -46.08M | -50.58M | -52.59M | -51.89M | -42.28M | -52.52M | -55.33M | -45.76M | -65.64M | -50.71M | -42.39M | -39.4M | -39.28M | -35.71M | -29.35M | -23.84M | -62.91M | -16.41M | 616K | -86.66M |
Selling & General & Admin | 11.04M | 17.41M | 14.74M | 11.21M | 13.12M | 13.28M | 12.3M | 14.1M | 12.6M | 11.16M | 13.08M | 10.49M | 10.66M | 9.15M | 9.63M | 6.61M | 7.37M | 6.22M | 7.19M | 3.03M | 1.16M | 1.39M |
Research & Development | 33.4M | 34.11M | 34.71M | 43.99M | 41.38M | 40.56M | 34.1M | 40.34M | 43.07M | 37.77M | 41.46M | 40.97M | 34.6M | 30.88M | 29.06M | 25.05M | 18.94M | 13.68M | 52.89M | 7.4M | 5.7M | 4.57M |
Other Expenses | n/a | -1.86M | n/a | -43.99M | -1.86M | n/a | n/a | n/a | n/a | -1.32M | 13.5M | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.57M |
Operating Expenses | 44.44M | 49.65M | 49.45M | 11.21M | 52.63M | 53.85M | 46.41M | 54.44M | 55.67M | 47.62M | 68.04M | 51.46M | 45.26M | 40.03M | 38.69M | 31.66M | 26.31M | 19.9M | 60.08M | 10.43M | 6.85M | 1.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 44.44M | 51.51M | 49.45M | 55.2M | 54.49M | 53.85M | 46.41M | 54.44M | 55.67M | 48.93M | 68.04M | 51.46M | 45.26M | 40.03M | 38.69M | 31.66M | 26.31M | 19.9M | 60.08M | 10.43M | 8.02M | 5.96M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -134K | 134K | n/a | -108K | 31K | -202K | -186K | 212K | -442K | -532K | 1.38M | -2.37M | 1.12M | -615K |
Shares Outstanding (Basic) | 177.22M | 177.1M | 148.76M | 160.5M | 129.19M | 130.88M | 118.6M | 119.76M | 119.19M | 104.47M | 97.38M | 91.85M | 90.47M | 89.06M | 97.21M | 97.21M | 95.73M | 95.73M | 95.73M | 95.73M | 95.73M | 95.73M |
Shares Outstanding (Diluted) | 177.22M | 177.1M | 148.76M | 160.5M | 129.19M | 130.88M | 118.6M | 119.76M | 119.19M | 104.47M | 97.38M | 91.85M | 90.47M | 89.06M | 97.21M | 97.21M | 95.73M | 95.73M | 95.73M | 95.73M | 95.73M | 95.73M |
EPS (Basic) | -0.24 | -0.28 | -0.26 | -0.32 | -0.41 | -0.40 | -0.36 | -0.44 | -0.46 | -0.44 | -0.67 | -0.55 | -0.47 | -0.44 | -0.42 | -0.37 | -0.37 | -0.31 | -0.72 | -0.24 | -0.04 | -0.92 |
EPS (Diluted) | -0.24 | -0.28 | -0.26 | -0.32 | -0.41 | -0.40 | -0.36 | -0.44 | -0.46 | -0.44 | -0.67 | -0.55 | -0.47 | -0.44 | -0.42 | -0.37 | -0.37 | -0.31 | -0.72 | -0.24 | -0.04 | -0.92 |
EBITDA | -40.32M | -47.27M | -44.2M | -48.7M | -50.73M | -50.19M | -40.56M | -50.96M | -53.92M | -44.31M | -53.3M | -50.22M | -41.24M | -38.55M | -38.6M | -28.51M | -29.36M | -24.08M | -61.3M | -18.62M | 2.9M | -5.91M |
EBIT | -42.11M | -49.12M | -46.08M | -50.58M | -52.59M | -51.89M | -42.28M | -52.52M | -55.46M | -45.63M | -54.54M | -51.46M | -42.35M | -39.6M | -39.47M | -29.14M | -29.79M | -24.37M | -61.53M | -18.78M | 1.73M | -5.96M |
Depreciation & Amortization | 1.79M | 1.86M | 1.88M | 1.88M | 1.86M | 1.7M | 1.72M | 1.56M | 1.54M | 1.32M | 1.25M | 1.24M | 1.12M | 1.05M | 870K | 631K | 430K | 293K | 229K | 167K | 1.16M | 50K |
Add to Watchlist
Select watchlists to add or remove PRME